Apollo endosurgery, inc. (APEN)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10
Revenues

50,713

60,854

-

-

-

-

-

-

-

-

Grant and royalty revenue

-

-

-

-

-

631

1,484

989

1,617

1,803

Research and development revenue under collaborative agreements

-

-

-

-

-

4,448

6,502

5,698

7,768

6,032

Revenues

-

-

64,310

64,650

67,790

5,080

7,986

6,688

9,386

7,835

Cost of sales

25,038

27,660

24,578

25,255

20,510

-

-

-

-

-

Gross margin

25,675

33,194

39,732

39,395

47,280

-

-

-

-

-

Operating expenses:
Sales and marketing

28,730

32,831

32,910

31,533

36,167

-

-

-

-

-

General and administrative

13,588

13,436

13,722

13,625

11,412

4,758

4,234

4,091

3,370

4,504

Research and development

10,384

12,176

8,299

7,805

9,558

18,126

11,343

8,158

9,726

7,819

Amortization of intangible assets

2,095

7,074

7,240

7,193

6,826

-

-

-

-

-

Settlement gain

5,609

0

-

-

-

-

-

-

-

-

Loss on divestiture

0

-7,770

0

-

-

-

-

-

-

-

Total operating expenses

49,188

73,287

62,171

60,156

63,963

22,885

15,578

12,249

13,096

12,324

Loss from operations

-23,513

-40,093

-22,439

-20,761

-16,683

-17,805

-7,591

-5,561

-3,710

-4,488

Other expenses:
Interest expense, net

4,052

4,063

4,508

18,168

10,036

-

-

-

-

-

Other expense (income), net

408

-1,440

-

-

-

0

26

-90

-4

-13

Other expense

-

-

41

1,851

663

-

-

-

-

-

Net loss before income taxes

-27,157

-45,596

-26,988

-40,780

-27,382

-

-

-

-

-

Income tax expense

275

191

304

387

49

-

-

-

-

-

Net loss

-27,432

-45,787

-27,292

-41,167

-27,431

-

-

-

-

-

Current dividends on convertible preferred stock

-

-

-

-

8,951

-

-

-

-

-

Change in fair value of warrants

-

-

-

-

-

-1,250

-

-

-

-

Change in fair value of warrants

-

-

-

-

-

-

1,000

2,900

600

-100

Total other income (expense), net

-

-

-

-

-

-

1,026

2,809

595

-113

Net loss attributable to common stockholders

-

-

-

-

-36,382

-16,555

-6,564

-2,752

-3,114

-4,602

Other comprehensive income (loss):
Foreign currency translation

-871

706

324

1,463

26

-

-

-

-

-

Comprehensive loss

-28,303

-45,081

-26,968

-39,704

-27,405

-

-

-

-

-

Net loss per share, basic and diluted (USD per share)

-1.27

-2.31

-2.01

-105.69

-151.90

-1.00

-0.49

-0.26

-0.35

-0.08

Shares used in computing net loss per share, basic and diluted (shares)

21,542

19,789

13,565

389

239

16,555

13,438

10,736

8,996

-

Basic (in shares)

-

-

-

-

-

-

-

-

-

55,765

Diluted (in shares)

-

-

-

-

-

-

-

-

-

55,765